Gongwin Biopharm Holdings Co (ROCO:6617) Other Current Liabilities: NT$0.02 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6617 Gongwin Biopharm Holdings Co Ltd ROCO:6617
48 GF Score
Price NT$96.30
! 2 Warning Signs
View Full Analysis

What is Gongwin Biopharm Holdings Co Other Current Liabilities?

Gongwin Biopharm Holdings Co ROCO:6617 +9.93% 48 Other Current Liabilities is NT$0.02 Mil as of Mar. 2026. GuruFocus rates ROCO:6617 with a GF Score™ of 48/100. The stock has 2 warning signs investors should review.

Gongwin Biopharm Holdings Co's other current liabilities for the quarter that ended in Mar. 2026 was NT$0.02 Mil.

Gongwin Biopharm Holdings Co's quarterly other current liabilities declined from Sep. 2025 (NT$0.23 Mil) to Dec. 2025 (NT$0.03 Mil) and declined from Dec. 2025 (NT$0.03 Mil) to Mar. 2026 (NT$0.02 Mil).

Gongwin Biopharm Holdings Co's annual other current liabilities increased from Dec. 2023 (NT$0.26 Mil) to Dec. 2024 (NT$0.27 Mil) but then declined from Dec. 2024 (NT$0.27 Mil) to Dec. 2025 (NT$0.03 Mil).

Gongwin Biopharm Holdings Co Other Current Liabilities Related Terms

Gongwin Biopharm Holdings Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Gongwin Biopharm Holdings Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gongwin Biopharm Holdings Co Other Current Liabilities Chart

Gongwin Biopharm Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.26 0.26 0.27 0.03

Gongwin Biopharm Holdings Co Quarterly Data
Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.24 0.23 0.03 0.02
ROCO:6617
48GF Score
Gongwin Biopharm Holdings Co Ltd ROCO:6617
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gongwin Biopharm Holdings Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of NT$0.02 Mil mean?
Gongwin Biopharm Holdings Co (ROCO:6617) has a Other Current Liabilities of NT$0.02 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gongwin Biopharm Holdings Co.
Is Gongwin Biopharm Holdings Co's Other Current Liabilities too high?
Gongwin Biopharm Holdings Co's current Other Current Liabilities is NT$0.02 Mil. Overall, Gongwin Biopharm Holdings Co has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Gongwin Biopharm Holdings Co's Other Current Liabilities compare to VRTX and REGN?
Gongwin Biopharm Holdings Co's Other Current Liabilities of NT$0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gongwin Biopharm Holdings Co. Gongwin Biopharm Holdings Co's current Other Current Liabilities is NT$0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gongwin Biopharm Holdings Co stock overvalued right now?
Gongwin Biopharm Holdings Co (ROCO:6617) has a current Other Current Liabilities of NT$0.02 Mil. The current Other Current Liabilities is NT$0.02 Mil. Gongwin Biopharm Holdings Co's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Gongwin Biopharm Holdings Co (ROCO:6617), the current Other Current Liabilities is NT$0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gongwin Biopharm Holdings Co Business Description

Address 3rd Floor, No.80, Jianguo North Road, Section 1, Zongshan District, Taipei, TWN, 10491
Gongwin Biopharm Holdings Co Ltd is a Taiwan-based biopharmaceutical company focused on developing novel anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma. The Group includes pharmaceutical research and development, drug testing, pharmaceutical technology consulting, biotechnology services, technology transfer, and the sale of new drugs.
48GF Score

Get the complete analysis for ROCO:6617

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$96.30
Price